MarketPeel
Insider Trading Intelligence
AG

Aaron Gorovitz

NRXP
DIRECTOR · NRX PHARMACEUTICALS, INC. · CIK 0001864536
FILING MIX · LIFETIME100%/0%
BUYS
4
SELLS
0
TOTAL VALUE
$11.2K
COMPANIES
1
ACTIVE SINCE
May 2021
HOLDINGS NOW
105,000
AVG SELL PX
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Aaron Gorovitz, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-15.80%-1.06%-14.74%-14.74%
14d1+0.00%-20.13%-1.00%-19.13%-19.13%
30d1+0.00%-17.98%-4.88%-13.10%-13.10%
60d1+100.00%+4.10%-7.53%+11.63%+11.63%
90d1+100.00%+4.89%+1.23%+3.66%+3.66%
180d1+100.00%+34.89%+13.04%+21.85%+21.85%
1y1+0.00%-42.27%+25.53%-67.80%-67.80%
2y1+0.00%-26.81%+46.40%-73.21%-73.21%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NRXP · 105,000 shares · as of Aug 30, 2023
040,66581,330121,995162,66020222023SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
FLOW · 4 buys / 0 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
NRXP
NRX PHARMACEUTICALS, INC.
PURCHASE
35,000$0.32$11.2K105,000Aug 30, 2023Sep 11, 2023View →
NRXP
NRX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
162,660162,660Oct 21, 2022Nov 22, 2022View →
NRXP
NRX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,67816,678May 24, 2021Jun 10, 2021View →
NRXP
NRX PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
8,3368,336May 24, 2021Jun 10, 2021View →
Other insiders · NRXP
Loading peer insiders…
About this filer
CIK 0001864536
ROLE
Director
PRIMARY
NRXP
COMPANIES
1
ACTIVE SINCE
May 2021
MARKETPEEL · /INSIDER/0001864536DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback